IND-arkiv - BioStock

Medivir’s CEO: “The IND approval is a very important milestone”

Medivir’s CEO: “The IND approval is a very important milestone”

16 December, 2024

Thomas Jonassen

SynAct Pharma’s CSO comments approved IND and Q3

4 November, 2022

BiBBInstruments Capital Raise

Cereno Scientific raises 95.3 million SEK

5 October, 2021

Cereno Scientific IND acceptance

Cereno Scientific receives IND acceptance for phase II start

21 September, 2021

BioStock’s article series on drug development: Making Treatments More Accessible

10 October, 2019

BioStock’s article series on Drug Development: The Process

1 October, 2019